INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Results

82,097 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
JM
Johnson Eric M.Chief Accounting Officer
VRTVertiv Holdings Co
Grant or award
A—
0 sh
Dec 18, 2025Dec 19, 2025
Page 1824 of 2053
← PrevNext →
traded Dec 18, 2025
+1d
SEC Form 4

Evidence

9
MK
Malady KyleEVP and Group CEO-VZ Business
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,731
150 sh
Dec 18, 2025Dec 19, 2025
traded Dec 18, 2025
+1dSEC Form 4

Evidence

9
PW
Pregenzer John WCOO & President, Electrical
ATKRAtkore Inc.
Grant or award
A—
132 sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

9
JW
James Wilbert W JrDirector
ATKRAtkore Inc.
Grant or award
A—
85 sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

9
WJ
Wauson Christopher J.See Remarks
USACUSA Compression Partners, LP
Option exercise
M—
13.1K sh
Dec 19, 2025Dec 19, 2025
traded Dec 19, 2025
+0dSEC Form 4

Evidence

9
LH
Litchfield HenryVP; General Counsel
BSVNBank7 Corp.
Tax withholding
F$5,687
127 sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

9
PF
Poncheri FrankChief Human Resources Officer
VRTVertiv Holdings Co
Grant or award
A—
2 sh
Dec 18, 2025Dec 19, 2025
traded Dec 18, 2025
+1dSEC Form 4

Evidence

9
PW
Porter Christopher WSee Remarks
USACUSA Compression Partners, LP
Option exercise
M—
18.6K sh
Dec 19, 2025Dec 19, 2025
traded Dec 19, 2025
+0dSEC Form 4

Evidence

9
HM
Hancock MarkDirector, Co Fndr; Int CFO; Exec V Chair, 10% Owner
PACSPACS Group, Inc.
Grant or award
A—
41.0K sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

9
MA
McEwen Julie A.See Remarks
USACUSA Compression Partners, LP
Disposition to issuer
D$39K
1,608 sh
Dec 19, 2025Dec 19, 2025
traded Dec 19, 2025
+0dSEC Form 4

Evidence

9
HM
Hancock MarkDirector, Co Fndr; Int CFO; Exec V Chair, 10% Owner
PACSPACS Group, Inc.
Grant or award
A—
150.0K sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

9
JW
Joustra WouterDirector
VORVor Biopharma Inc.
Grant or award
A—
3,000 sh
Dec 18, 2025Dec 19, 2025
traded Dec 18, 2025
+1dSEC Form 4

Evidence

9
GC
Gibson ChristopherDirector, Chief Executive Officer
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$180K
40.0K sh
Dec 19, 2025Dec 19, 2025
traded Dec 19, 2025
+0dSEC Form 4

Evidence

9
CC
Chamberlin CraigChief Financial Officer
VRTVertiv Holdings Co
Grant or award
A—
2 sh
Dec 18, 2025Dec 19, 2025
traded Dec 18, 2025
+1dSEC Form 4

Evidence

9
PM
Pulvermueller Patrick MichaelDirector
NABLN-able, Inc.
Grant or award
A—
47.5K sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

9
SS
Sampath SowmyanarayanEVP and Group CEO-VZ Consumer
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,962
170 sh
Dec 18, 2025Dec 19, 2025
traded Dec 18, 2025
+1dSEC Form 4

Evidence

9
MA
McEwen Julie A.See Remarks
USACUSA Compression Partners, LP
Option exercise
M—
3,215 sh
Dec 19, 2025Dec 19, 2025
traded Dec 19, 2025
+0dSEC Form 4

Evidence

9
VV
Venkatesh VandanaEVP and Chief Legal Officer
VZVERIZON COMMUNICATIONS INC
Grant or award
A$1,270
110 sh
Dec 18, 2025Dec 19, 2025
traded Dec 18, 2025
+1dSEC Form 4

Evidence

9
EJ
Edwards Barbara JoanneDirector
ATKRAtkore Inc.
Grant or award
A—
15 sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

9
RP
Ryan PaulChief Procurement Officer
VRTVertiv Holdings Co
Grant or award
A—
3 sh
Dec 18, 2025Dec 19, 2025
traded Dec 18, 2025
+1dSEC Form 4

Evidence

9
GL
Gill Stephanie LChief Legal Counsel & Sec.
VRTVertiv Holdings Co
Grant or award
A—
8 sh
Dec 18, 2025Dec 19, 2025
traded Dec 18, 2025
+1dSEC Form 4

Evidence

9
LD
Levin Andrew DavidDirector
VORVor Biopharma Inc.
Grant or award
A—
3,000 sh
Dec 18, 2025Dec 19, 2025
traded Dec 18, 2025
+1dSEC Form 4

Evidence

9
GM
Giresi MichaelChief Information Officer
VRTVertiv Holdings Co
Grant or award
A—
1 sh
Dec 18, 2025Dec 19, 2025
traded Dec 18, 2025
+1dSEC Form 4

Evidence

9
GS
Gasperment SophieDirector
CMPRCIMPRESS plc
Grant or award
A—
2,687 sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

9
KA
Kershaw Justin ADirector
ATKRAtkore Inc.
Grant or award
A—
93 sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

8
GM
Gardner Jason M.Director, 10% Owner
MQMarqeta, Inc.
Open-market sale · 10b5-1 plan
SELL$33K
6,653 sh
Dec 19, 2025Dec 19, 2025
traded Dec 19, 2025
+0dSEC Form 4

Evidence

7
SL
Soroca Adam LeeCHIEF PRODUCT OFFICER
MGNIMAGNITE, INC.
Option exercise · 10b5-1 plan
M—
16.7K sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

6
SL
Soroca Adam LeeCHIEF PRODUCT OFFICER
MGNIMAGNITE, INC.
Option exercise · 10b5-1 plan
M$82K
16.7K sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

6
SJ
Sellers JeanetteSVP of Accounting
NCNOnCino, Inc.
Open-market sale · 10b5-1 plan
SELL$37K
1,507 sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

5
LF
Lamps Mark F.Pres. Safety & Infrastructure
ATKRAtkore Inc.
Grant or award
A—
68 sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

5
FJ
Fox-Geen JeremyChief Financial Officer
CRCLCircle Internet Group, Inc.
Option exercise
M—
39.6K sh
Dec 18, 2025Dec 19, 2025
traded Dec 18, 2025
+1dSEC Form 4

Evidence

4
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$723K
45.0K sh
Dec 19, 2025Dec 19, 2025
traded Dec 19, 2025
+0dSEC Form 4

Evidence

0
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
2,500 sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector, Chief Executive Officer
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Dec 19, 2025Dec 19, 2025
traded Dec 19, 2025
+0dSEC Form 4

Evidence

0
GC
Gibson ChristopherDirector, Chief Executive Officer
RXRXRECURSION PHARMACEUTICALS, INC.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Dec 19, 2025Dec 19, 2025
traded Dec 19, 2025
+0dSEC Form 4

Evidence

0
RM
Rizik MatthewDirector
RKTRocket Companies, Inc.
Open-market sale · 10b5-1 plan
SELL$47K
2,500 sh
Dec 18, 2025Dec 19, 2025
traded Dec 18, 2025
+1dSEC Form 4

Evidence

0
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Derivative conversion · 10b5-1 plan
C—
50.0K sh
Dec 17, 2025Dec 19, 2025
traded Dec 17, 2025
+2dSEC Form 4

Evidence

53
CC
Clark Casey CollinsPresident and CIO, RAM
RKMIXRockefeller Municipal Opportunities Fund
Open-market purchase
BUY$325K
16.3K sh
Dec 15, 2025Dec 18, 2025
traded Dec 15, 2025
+3dSEC Form 4

Evidence

46
KD
Kaster DeborahChief Financial Officer
ADGMAdagio Medical Holdings, Inc.
Open-market purchase
BUY$18K
15.0K sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC Form 4

Evidence